The molecular mechanism analysis revealed that the active components of WGP have a positive influence on the four potentially important therapeutic targets of aging, atherosclerosis, or fatigue (i.e., FOS, ESR1, MAPK8, and SP1). The gene discussed is MAPK8; the disease is atherosclerosis.